alprazolam has been researched along with sertraline in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 12 (66.67) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Busto, U; Kaplan, HL; Sellers, EM; Zawertailo, LA | 1 |
| Alderman, J; Greenblatt, DJ; Horst, WD; Preskorn, SH | 1 |
| Brissie, RM; Davis, GG; Hall, M; Milner, DA; Robinson, CA | 1 |
| Hassan, PC; Herrmann, N; Naranjo, CA; Sproule, BA | 1 |
| Greenblatt, DJ; Harvey, AT; Preskorn, SH | 1 |
| Stahl, SM | 1 |
| Rickels, K; Rynn, M | 1 |
| Cheng, KT; DeVane, CL; Donovan, JL; Liston, HL; Markowitz, JS; Risch, SC; Willard, L | 1 |
| Fiseković, S; Loga-Zec, S | 1 |
| Celik, L; Kaynak, S; Kaynak, T; Kocak, N; Ozerdem, A | 1 |
| Ahn, SC; Choi, TK; Lee, SH; Lee, YJ; Suh, SY; Yook, KH | 1 |
| Benjamin, AB | 1 |
| Keshetty, S; Pai, MG; Venisetty, RK; Venkateswarlu, K; Yellu, NR | 1 |
| Koval'chuk, VV | 1 |
| Esfahani, H; Golbaz, S; Nabizadeh, R; Rastkari, N; Yaghmaeian, K; Zamanzadeh, M | 1 |
2 review(s) available for alprazolam and sertraline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacotherapy of generalized anxiety disorder.
Topics: Algorithms; Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Buspirone; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Drug Administration Schedule; Humans; Paroxetine; Psychotherapeutic Processes; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
7 trial(s) available for alprazolam and sertraline
| Article | Year |
|---|---|
Comparative abuse liability of sertraline, alprazolam, and dextroamphetamine in humans.
Topics: 1-Naphthylamine; Adolescent; Adult; Alprazolam; Arousal; Attention; Attitude; Dextroamphetamine; Double-Blind Method; Euphoria; Humans; Male; Middle Aged; Psychomotor Performance; Risk Factors; Secobarbital; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance-Related Disorders | 1995 |
Dose-response evaluation of the interaction between sertraline and alprazolam in vivo.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Female; Humans; Male; Mental Recall; Mixed Function Oxygenases; Neuropsychological Tests; Psychomotor Performance; Sertraline | 2000 |
Lack of effect of sertraline on the pharmacokinetics of alprazolam.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Area Under Curve; Drug Interactions; Half-Life; Humans; Sertraline | 2000 |
Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers.
Topics: Administration, Oral; Adult; Alprazolam; Area Under Curve; Breath Tests; Carbon Radioisotopes; Cross-Over Studies; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Delayed-Action Preparations; Drug Administration Schedule; Erythromycin; Fluoxetine; Half-Life; Humans; Male; Middle Aged; Molecular Probes; Piperazines; Sertraline; Triazoles; Venlafaxine Hydrochloride | 2004 |
Sertraline and alprazolam in the treatment of panic desorder.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Outpatients; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2005 |
Effectiveness of a meditation-based stress management program as an adjunct to pharmacotherapy in patients with anxiety disorder.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Combined Modality Therapy; Fluvoxamine; Humans; Meditation; Paroxetine; Program Development; Self Care; Sertraline; Stress, Psychological; Surveys and Questionnaires | 2007 |
[Pharmacologic correction of psycho-emotive disorders in the rehabilitation of patients after removal of brain tumors].
Topics: Adult; Alprazolam; Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Brain Neoplasms; Depression; Doxepin; Emotions; Female; Humans; Male; Maprotiline; Middle Aged; Moclobemide; Mood Disorders; Neurosurgical Procedures; Nialamide; Sertraline; Thiazepines; Trazodone; Treatment Outcome | 2007 |
9 other study(ies) available for alprazolam and sertraline
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Sertraline does not inhibit cytochrome P450 3A-mediated drug metabolism in vivo.
Topics: 1-Naphthylamine; Adolescent; Adult; Alprazolam; Aryl Hydrocarbon Hydroxylases; Biotransformation; Carbamazepine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Humans; Male; Middle Aged; Oxidoreductases, N-Demethylating; Selective Serotonin Reuptake Inhibitors; Sertraline; Substrate Specificity; Terfenadine | 1997 |
Fatal multiple drug intoxication following acute sertraline use.
Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Chromatography, High Pressure Liquid; Drug Interactions; Drug Overdose; Fatal Outcome; Gas Chromatography-Mass Spectrometry; Humans; Male; Middle Aged; Sertraline; Suicide | 1998 |
Don't ask, don't tell, but benzodiazepines are still the leading treatments for anxiety disorder.
Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Drug Therapy, Combination; Humans; Practice Guidelines as Topic; Practice Patterns, Physicians'; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Sertraline; Treatment Outcome | 2002 |
Disappointment of patients on antidepressant therapy after excimer laser treatment.
Topics: Adult; Alprazolam; Antidepressive Agents; Dry Eye Syndromes; Female; Humans; Keratomileusis, Laser In Situ; Middle Aged; Mydriasis; Myopia; Paroxetine; Patient Satisfaction; Patients; Sertraline; Vision Disorders | 2006 |
Medication management with panic disorder in the exercise state: some prescribing guidelines.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Dose-Response Relationship, Drug; Drug Prescriptions; Exercise; Heart Rate; Humans; Male; Panic Disorder; Practice Guidelines as Topic; Sertraline; Severity of Illness Index | 2007 |
Development of HPTLC-UV absorption densitometry method for the analysis of alprazolam and sertraline in combination and its application in the evaluation of marketed preparations.
Topics: Alprazolam; Anti-Anxiety Agents; Chromatography, Thin Layer; Reference Standards; Selective Serotonin Reuptake Inhibitors; Sertraline; Spectrophotometry, Ultraviolet | 2007 |
Occurrence and removal of psychiatric pharmaceuticals in the Tehran South Municipal Wastewater Treatment Plant.
Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Citalopram; Environmental Monitoring; Humans; Hypnotics and Sedatives; Iran; Pharmaceutical Preparations; Sertraline; Thioridazine; Venlafaxine Hydrochloride; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Purification | 2023 |